Literature DB >> 351404

Post-anoxic action myoclonus: improvement with valproic acid.

S Fahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 351404     DOI： 10.1056/nejm197808102990621

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Catamenial exacerbation of action myoclonus: successful treatment with acetazolamide.

Authors:  M G Goetting
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

Review 2.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

3.  Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.

Authors:  K-K Tai; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

4.  Improvement of Post-hypoxic Myoclonus with Bilateral Pallidal Deep Brain Stimulation: A Case Report and Review of the Literature.

Authors:  Ritesh A Ramdhani; Steven J Frucht; Brian H Kopell
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-05-19

Review 5.  Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment.

Authors:  Harsh V Gupta; John N Caviness
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.